TUESDAY, March 25, 2025 (HealthDay News) — Statins are very cheap and highly effective cholesterol-lowering drugs — but high-risk heart patients may have an even better option, a new evidence review says. Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, accordingContinue Reading

MONDAY, March 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of people.  The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals and is used to treat transthyretin amyloid cardiomyopathy (ATTR-CM). ATTR-CM isContinue Reading